US Pharma MarketingDriven by GLP-1s, pharma’s relationship with consumers is starting to change
The rise of direct-to-consumer channels, driven largely by consumer willingness to pay for GLP-1s for weight loss without using insurance, is leading to new arrangements between pharmaceutical companies and employers that oversee healthcare coverage for their employees. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next…
Pharmaceutical companies’ ability to interact with the patients taking their medications has changed over the last few years.
The rise of direct-to-consumer channels, driven largely by consumer willingness to pay for GLP-1s for weight loss ...
Source: Endpoints News